Literature DB >> 16934474

Dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos disease).

Borut Prestor1.   

Abstract

Dysplastic gangliocytoma of the cerebellum is a rare disorder requiring surgical resection. During surgical exploration, the margin with normal cerebellar tissue is often not distinct. We present here a case in which we surgically treated a patient with Lhermitte-Duclos disease, and discuss radical resection of the tumour. The patient was first admitted at the age of 34 years. A MRI scan revealed a large left cerebellar mass typical of dysplastic gangliocytoma. Postoperatively the patient developed severe cerebellar syndrome with only partial recovery after 4 years. MRI revealed no impairment of cerebrospinal fluid circulation; the mass in the left cerebellum had been removed, and no recurrent disease was visible. Clinical problems after gross total or complete removal of Lhermitte-Duclos lesions have not been reported in the literature, but herein we stress the importance of extreme caution in removing these lesions in cerebellar areas that have no distinct border between the tumour and normal tissue.

Entities:  

Mesh:

Year:  2006        PMID: 16934474     DOI: 10.1016/j.jocn.2005.07.018

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  A surgically treated case of Lhermitte-Duclos disease with a precise natural history and high uptake of FDG on PET.

Authors:  Yuko Goto; Naoya Hashimoto; Yoshiko Okita; Tetsu Goto; Carter Rabo; Hiroshi Hirayama; Yoshiharu Horikawa; Manabu Kinoshita; Naoki Kagawa; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2009-11-12       Impact factor: 4.130

2.  Management of unusual dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos disease) in a developing country: Case report and review of the literature.

Authors:  Nyoman Golden; Mahadewa G B Tjokorda; Maliawan Sri; Wayan Niryana; Saputra Herman
Journal:  Asian J Neurosurg       Date:  2016 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.